1. FDA updates on angiotensin II receptor blocker (ARB) recalls including valsartan, losartan and irbesartan. https://www.fda.gov/Drugs/DrugSafety/ucm613916.htm (Last accessed: 01. April 2019).
2. Committee for Medicinal Products for Human Use (16. July 2018) CHMP List of questions - To be addressed by the API manufacturers for valsartan-containing medicinal products (Procedure number: EMEA/H/A-31/1471). European Medicines Agency - London, United Kingdom https://wwwemaeuropaeu/en/documents/referral/valsartan-article-31-referral-chmp-list-questions-be-addressed-api-manufacturers-valsartan_enpdf.
3. Noch mehr Nitrosamine - NDMA, NDEA, NDIPA - wie kommen die Verunreinigungen in die Sartane?;Buschmann;In: Deutsche Apotheker Zeitung,2019
4. FDA Provides Update on Its Ongoing Investigation Into Valsartan Products; and Reports on the Finding of an Additional Impurity Identified in One Firm’s Already Recalled Products;U.S. Food & Drug Administration,2018
5. Valsartan: ZL findet NDMA in Tabletten;Abdel-Tawab;Pharm. (1856),2018